Clinical Applicability of a Proposed Algorithm for Referral to Hematologic Genetic Screening of Patients Diagnosed with Acute Myeloid Leukemia (AML), Aplastic Anemia (AA) and Myelodysplastic Syndrome (MDS) in a Community Based Hospital